Director, Regulatory Affairs
Tris Pharma, Inc., Trenton, NJ, United States
Description
Tris Pharma, Inc. (www.trispharma.com) is a leading privately‑owned US biopharmaceutical company focused on development and commercialization of innovative medicines in ADHD, spectrum disorders, anxiety, pain and addiction addressing unmet patient needs. We have >150 US and International patents and market several branded ADHD products in the US. We also license our products in the US and ex‑US markets. Our robust pipeline of innovative products employing our proprietary science and technology spans neuroscience and other therapeutic categories.
Our science and technology make us unique, but our team members set us apart; they’re the engine fueling Tris’ passion and innovation. Our colleagues understand the criticality of operating a successful business and take pride in the company’s success. Equally important is how we interact on a daily basis. We believe in each other and in respectful, open and honest communication to help support individual and team success.
Key Responsibilities NDA Strategy Execution
Support Regulatory Affairs Lead in implementing regulatory strategy for 505(b)(1) NCE NDA
Provide pragmatic, experience‑based regulatory input informed by recent FDA interactions and division expectations, particularly in analgesia/pain
Contribute to FDA meeting preparation (mid and/or late‑cycle) including briefing documents, questions, response planning to IRs, etc.
Hands‑On NDA Submission Management
Day‑to‑day driver of NDA submission activities, managing timelines, dependencies and deliverables
Lead and/or directly support preparation, integration, review of NDA Modules 1–5
Ensure submission content is clear, consistent, inspection‑ready (manage communications with QA) and aligned with FDA expectations
Cross‑Functional Leadership in a Lean Environment
Acts as Regulatory execution point alongside Regulatory Lead across Clinical, CMC, Nonclinical, Biostatistics, Medical Writing, Labeling and external partners
Drives content planning and readiness, proactively identifying risks and proposing solutions
Provides oversight of technical publishing, QC activities and final eCTD submission assembly
Review, Quality, FDA Interactions
Perform detailed regulatory reviews ensuring compliance with FDA regulations, guidance and internal standards
Support responses to FDA information requests during filing review and post‑submission
Assist with labeling development and negotiation support, as appropriate for program stage.
Support documentation and team preparation/practice for potential Advisory Committee Meetings
Requirements Required Qualifications
Bachelors degree in science or a related discipline (Advanced degree PREFERRED) and minimum 10 years Regulatory Affairs experience in the pharmaceutical, biotechnology or related industry in positions of increasing technical and strategic responsibility REQUIRED
Current hands‑on experience supporting or leading 505(b)(1) NCE NDA submissions REQUIRED
Proven experience authoring, reviewing and managing NDA modules (not strategy‑only) REQUIRED
Strong working knowledge of FDA regulations, guidance and eCTD requirements REQUIRED
Ability to operate effectively in a small biotech setting with limited infrastructure REQUIRED
Experience interacting with FDAs Analgesia/Pain Division (DAAAP or successor) PREFERRED
Background in pain, CNS or controlled substance programs PREFERRED
Work Arrangements: We are a HYBRID work environment requiring candidates to be able to work majority of week in our NJ office.
Anticipated salary range $200 to $245K/yr. Base salary offered is contingent on assessment of candidate’s education and experience level relative to requirements of the position and a review of related industry standards and internal equity.
Additional benefits In addition to base salary, full‑time employees are also eligible for incentives, including, but not limited to: bonus eligible, medical, dental, vision, Rx insurance, 401K with match, life insurance, paid Company Holidays, PTO, Paid Volunteer Time and Employee Resource Groups.
Tris Pharma, Inc. offers a highly competitive compensation and benefits package. To build and enhance our diverse workforce, we encourage applications from individuals with disabilities, minorities, veterans, women, LGBTQ, etc. Tris Pharma, Inc. is an Equal Opportunity Employer. #LI‑hybrid
#J-18808-Ljbffr
Our science and technology make us unique, but our team members set us apart; they’re the engine fueling Tris’ passion and innovation. Our colleagues understand the criticality of operating a successful business and take pride in the company’s success. Equally important is how we interact on a daily basis. We believe in each other and in respectful, open and honest communication to help support individual and team success.
Key Responsibilities NDA Strategy Execution
Support Regulatory Affairs Lead in implementing regulatory strategy for 505(b)(1) NCE NDA
Provide pragmatic, experience‑based regulatory input informed by recent FDA interactions and division expectations, particularly in analgesia/pain
Contribute to FDA meeting preparation (mid and/or late‑cycle) including briefing documents, questions, response planning to IRs, etc.
Hands‑On NDA Submission Management
Day‑to‑day driver of NDA submission activities, managing timelines, dependencies and deliverables
Lead and/or directly support preparation, integration, review of NDA Modules 1–5
Ensure submission content is clear, consistent, inspection‑ready (manage communications with QA) and aligned with FDA expectations
Cross‑Functional Leadership in a Lean Environment
Acts as Regulatory execution point alongside Regulatory Lead across Clinical, CMC, Nonclinical, Biostatistics, Medical Writing, Labeling and external partners
Drives content planning and readiness, proactively identifying risks and proposing solutions
Provides oversight of technical publishing, QC activities and final eCTD submission assembly
Review, Quality, FDA Interactions
Perform detailed regulatory reviews ensuring compliance with FDA regulations, guidance and internal standards
Support responses to FDA information requests during filing review and post‑submission
Assist with labeling development and negotiation support, as appropriate for program stage.
Support documentation and team preparation/practice for potential Advisory Committee Meetings
Requirements Required Qualifications
Bachelors degree in science or a related discipline (Advanced degree PREFERRED) and minimum 10 years Regulatory Affairs experience in the pharmaceutical, biotechnology or related industry in positions of increasing technical and strategic responsibility REQUIRED
Current hands‑on experience supporting or leading 505(b)(1) NCE NDA submissions REQUIRED
Proven experience authoring, reviewing and managing NDA modules (not strategy‑only) REQUIRED
Strong working knowledge of FDA regulations, guidance and eCTD requirements REQUIRED
Ability to operate effectively in a small biotech setting with limited infrastructure REQUIRED
Experience interacting with FDAs Analgesia/Pain Division (DAAAP or successor) PREFERRED
Background in pain, CNS or controlled substance programs PREFERRED
Work Arrangements: We are a HYBRID work environment requiring candidates to be able to work majority of week in our NJ office.
Anticipated salary range $200 to $245K/yr. Base salary offered is contingent on assessment of candidate’s education and experience level relative to requirements of the position and a review of related industry standards and internal equity.
Additional benefits In addition to base salary, full‑time employees are also eligible for incentives, including, but not limited to: bonus eligible, medical, dental, vision, Rx insurance, 401K with match, life insurance, paid Company Holidays, PTO, Paid Volunteer Time and Employee Resource Groups.
Tris Pharma, Inc. offers a highly competitive compensation and benefits package. To build and enhance our diverse workforce, we encourage applications from individuals with disabilities, minorities, veterans, women, LGBTQ, etc. Tris Pharma, Inc. is an Equal Opportunity Employer. #LI‑hybrid
#J-18808-Ljbffr